1. Home
  2. INDP vs XELB Comparison

INDP vs XELB Comparison

Compare INDP & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • XELB
  • Stock Information
  • Founded
  • INDP 2000
  • XELB 2011
  • Country
  • INDP United States
  • XELB United States
  • Employees
  • INDP N/A
  • XELB N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • XELB Multi-Sector Companies
  • Sector
  • INDP Health Care
  • XELB Miscellaneous
  • Exchange
  • INDP Nasdaq
  • XELB Nasdaq
  • Market Cap
  • INDP 7.4M
  • XELB 6.0M
  • IPO Year
  • INDP N/A
  • XELB N/A
  • Fundamental
  • Price
  • INDP $0.35
  • XELB $1.98
  • Analyst Decision
  • INDP Strong Buy
  • XELB
  • Analyst Count
  • INDP 2
  • XELB 0
  • Target Price
  • INDP $8.50
  • XELB N/A
  • AVG Volume (30 Days)
  • INDP 757.0K
  • XELB 85.7K
  • Earning Date
  • INDP 05-14-2025
  • XELB 06-04-2025
  • Dividend Yield
  • INDP N/A
  • XELB N/A
  • EPS Growth
  • INDP N/A
  • XELB N/A
  • EPS
  • INDP N/A
  • XELB N/A
  • Revenue
  • INDP N/A
  • XELB $7,407,000.00
  • Revenue This Year
  • INDP N/A
  • XELB $82.36
  • Revenue Next Year
  • INDP N/A
  • XELB $27.96
  • P/E Ratio
  • INDP N/A
  • XELB N/A
  • Revenue Growth
  • INDP N/A
  • XELB N/A
  • 52 Week Low
  • INDP $0.31
  • XELB $2.00
  • 52 Week High
  • INDP $2.89
  • XELB $8.49
  • Technical
  • Relative Strength Index (RSI)
  • INDP 39.89
  • XELB 38.28
  • Support Level
  • INDP $0.31
  • XELB $2.31
  • Resistance Level
  • INDP $0.37
  • XELB $2.90
  • Average True Range (ATR)
  • INDP 0.04
  • XELB 0.33
  • MACD
  • INDP 0.00
  • XELB -0.04
  • Stochastic Oscillator
  • INDP 26.55
  • XELB 4.03

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: